A share price of GE HealthCare Technologies Inc [GEHC] is currently trading at $87.64, up 3.13%. An important factor to consider is whether the stock is rising or falling in short-term value. The GEHC shares have gain 5.37% over the last week, with a monthly amount glided 18.96%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 19, February 2024, Serving Patients and Communities Through Comprehensive Care Solutions: OSF HealthCare, Pointcore, Inc. and GE HealthCare Enter Strategic Care Alliance. In a post published today on Yahoo Finance, 10-year collaboration aims to expand the reach of innovative technology and digital solutions to more than one million patients.
From an analyst’s perspective:
GE HealthCare Technologies Inc [NASDAQ: GEHC] stock has seen the most recent analyst activity on February 15, 2024, when HSBC Securities initiated its Buy rating and assigned the stock a price target of $100. Previously, UBS upgraded its rating to Neutral on February 12, 2024, and elevated its price target to $88. On November 30, 2023, Jefferies initiated with a Hold rating and assigned a price target of $80 on the stock. UBS downgraded its rating to a Sell and decreased its price target to $66 on November 27, 2023. Citigroup initiated its recommendation with a Buy and recommended $82 as its price target on September 19, 2023. Argus started tracking with a Buy rating for this stock on August 25, 2023, and assigned it a price target of $80. In a note dated August 16, 2023, Wells Fargo initiated an Overweight rating and provided a target price of $90 on this stock.
GE HealthCare Technologies Inc experienced fluctuations in its stock price throughout the past year between $62.35 and $87.83. Currently, Wall Street analysts expect the stock to reach $86.5 within the next 12 months. GE HealthCare Technologies Inc [NASDAQ: GEHC] shares were valued at $87.64 at the most recent close of the market. An investor can expect a potential drop of -1.3% based on the average GEHC price forecast.
Analyzing the GEHC fundamentals
Trailing Twelve Months sales for GE HealthCare Technologies Inc [NASDAQ:GEHC] were 19.55B which represents 5.43% growth. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 85.73 points at the first support level, and at 83.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 88.82, and for the 2nd resistance point, it is at 90.01.
GE HealthCare Technologies Inc [GEHC] reported earnings per share of $1.18 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $1.07/share, meaning a difference of $0.11 and a surprise factor of 10.30%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.99 per share as compared to estimates of $0.9 per share, a difference of $0.09 representing a surprise of 10.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for GE HealthCare Technologies Inc [NASDAQ:GEHC] is 1.00. On the other hand, the Quick Ratio is 0.78, and the Cash Ratio is 0.05. Considering the valuation of this stock, the price to sales ratio is 2.04, the price to book ratio is 5.59 and price to earnings (TTM) ratio is 28.97.
Transactions by insiders
Recent insider trading involved O’Neill Kevin Michael, CEO, PDx, that happened on Jul 31 when 15609.0 shares were sold. CEO, Ultrasound, Rott Roland completed a deal on Jun 08 to sell 2473.0 shares. Meanwhile, CEO, Imaging Makela Jan sold 70629.0 shares on Mar 14.
